To validate if the previous results are due to ADT or tumour heterogeneity, PD-L1 expression, CD8+ T-cell infiltration, and CD8+ T-cell activity were assessed in an exploratory study using a longitudinal patient cohort. This evidence concerns the gene CD8A and neoplasm.